| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |